Chemoinformaics analysis of 4-HYDROXYBENZOYL GLUCOSE
| Molecular Weight | 300.263 | nRot | 3 |
| Heavy Atom Molecular Weight | 284.135 | nRig | 13 |
| Exact Molecular Weight | 300.085 | nRing | 2 |
| Solubility: LogS | -1.435 | nHRing | 1 |
| Solubility: LogP | -0.675 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 38.7947 |
| nHD | 5 | BPOL | 20.3913 |
| QED | 0.419 |
| Synth | 3.352 |
| Natural Product Likeliness | 1.915 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.034 |
| HIA | 0.849 |
| CACO-2 | -5.886 |
| MDCK | 0.000315935 |
| BBB | 0.757 |
| PPB | 0.276801 |
| VDSS | 0.39 |
| FU | 0.630113 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.033 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.285 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.197 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.023 |
| CL | 3.008 |
| T12 | 0.707 |
| hERG | 0.022 |
| Ames | 0.08 |
| ROA | 0.051 |
| SkinSen | 0.036 |
| Carcinogencity | 0.061 |
| EI | 0.023 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.805722 |